Surendra Kumar Nayak

机构：Bristol-Myers Squibb (United States) · ORCID：0000-0002-3544-8791

发表论文 81 篇 · 总被引 2630 次 · h-index 23

代表论文

• Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review (2021 · Chemical Biology & Drug Design · 被引 350)
• A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery and Developments (2018 · Current Drug Discovery Technologies · 被引 86)
• An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus (2019 · Current Diabetes Reviews · 被引 84)
• Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation (2023 · Journal of Medicinal Chemistry · 被引 53)
• Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells (2024 · Nature Communications · 被引 45)
• DESIGN AND MOLECULAR DOCKING STUDIES OF NOVEL ANTIMICROBIAL PEPTIDES USING AUTODOCK MOLECULAR DOCKING SOFTWARE (2017 · Asian Journal of Pharmaceutical and Clinical Research · 被引 44)